project id: TCGA-HNSC; case submitter id: TCGA-CV-A45W; source center: 23; state: released; a260 a280 ratio: 1.98; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.3; rna integrity number: 8.1; age at index: 75; days to birth: -27743; days to death: 1398; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Dead; year of birth: 1924; year of death: 2002; age at diagnosis: 27743; ajcc clinical m: M0; ajcc clinical n: N0; ajcc clinical stage: Stage III; ajcc clinical t: T3; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage II; ajcc pathologic t: T2; ajcc staging system edition: 5th; classification of tumor: not reported; days to diagnosis: 0; icd 10 code: C32.9; last known disease status: not reported; morphology: 8070/3; primary diagnosis: Squamous cell carcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Larynx, NOS; synchronous malignancy: No; tissue or organ of origin: Larynx, NOS; tumor grade: Not Reported; year of diagnosis: 1999; treatment or therapy: no; alcohol history: Yes; is ffpe: false; composition: Not Reported; days to collection: 4786; days to sample procurement: 0; initial weight: 50.0; portion submitter id: TCGA-CV-A45W-01A-11; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 10.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 25.0; percent tumor cells: 65.0; percent tumor nuclei: 80.0;